Latest News about Briefs
Recent news which mentions Briefs
Littelfuse Stock Rises On Q2 Earnings Beat, Guides Q3 Above Consensus, Boosts Dividend By 10%
Today 14:48 EDT
Tickers
LFUS
From Benzinga
Silicon Labs Stock Gains On Q2 Earnings; Matt Johnson To Succeed Tyson Tuttle As CEO In 2022
Today 14:22 EDT
From Benzinga
Third Dose Of Pfizer-BioNTech's COVID-19 Vaccine Boosts Protection Against Delta Variant, New Data Reveals
Today 14:21 EDT
From Benzinga
EU Set To Penalize WhatsApp Over User Privacy Violation: Report
Today 14:16 EDT
From Benzinga
From Benzinga
M/I Homes Stock Gains On Q2 Earnings Beat, Improved Margins
Today 13:29 EDT
Tickers
MHO
From Benzinga
From Benzinga
From Benzinga
Amphenol Beats On Q2 Earnings, Posts Robust Q3 Guidance
Today 12:47 EDT
From Benzinga
iHeartMedia, NBA Forge Multi-Year Podcast Partnership
Today 12:43 EDT
From Benzinga
Dynatrace Beats On Q1 Earnings, Issues Strong Q2 Guidance
Today 12:40 EDT
From Benzinga
From Benzinga
No Increased Risk Of Blood Clots After Second Dose Of AstraZeneca's COVID-19 Shot, Study Shows
Today 12:19 EDT
Tickers
AZN
From Benzinga
Chefs' Warehouse Stock Gains As Q2 Results Smashes Estimates
Today 12:06 EDT
Tickers
CHEF
From Benzinga
From Benzinga
From Benzinga
Wingstop Stock Falls On Slow Same-Store Sales Growth In Q2; Raises Quarterly Dividend By 21%
Today 11:33 EDT
Tickers
WING
From Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
Today 11:33 EDT
From Benzinga
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
Today 11:22 EDT
From Benzinga
PolarityTE's SkinTE Meets Primary, Secondary Endpoint Goals In Diabetic Foot Ulcer Trial
Today 11:01 EDT
Tickers
PTE
From Benzinga
Asensus Surgical Stock Gains On FDA Approval For Articulating Instruments For Its Surgical System
Today 10:58 EDT
Tickers
ASXC
From Benzinga
Travel + Leisure Stock Falls On Disappointing FY21 EPS Outlook
Today 10:53 EDT
Tickers
TNL
From Benzinga
Abeona Stock Gains As It Concludes Type B Meeting With FDA For MPS IIIA Gene Therapy
Today 10:53 EDT
Tickers
ABEO
From Benzinga
I-Mab Stock Moves Higher As IND For Mid-Stage Efineptakin Cancer Trial Accepted By China
Today 10:50 EDT
Tickers
IMAB
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.